Arcus Biosciences, Inc. (RCUS) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "RCUS"
      ],
      "issuer_cik": "0001724521",
      "owner_cik": "0001771961",
      "accession_number": "0001771961-26-000006",
      "form_type": "4",
      "filing_date": "2026-08-24",
      "period_of_report": "2026-08-21",
      "issuer_name": "Arcus Biosciences, Inc.",
      "issuer_trading_symbol": "RCUS",
      "owner_name": "Azoy Alexander",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Chief Accounting Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-08-21",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 2827,
      "transaction_price_per_share": 30,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 39581,
      "transaction_value": 84810,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."
        },
        {
          "id": "F2",
          "description": "Includes the unvested portion of the Reporting Person's RSU grants."
        }
      ]
    },
    {
      "tickers": [
        "RCUS"
      ],
      "issuer_cik": "0001724521",
      "owner_cik": "0001422996",
      "accession_number": "0001422996-26-000006",
      "form_type": "4",
      "filing_date": "2026-07-13",
      "period_of_report": "2026-07-09",
      "issuer_name": "Arcus Biosciences, Inc.",
      "issuer_trading_symbol": "RCUS",
      "owner_name": "Jaen Juan C.",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "President",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-07-09",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 48502,
      "transaction_price_per_share": 30.053,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 842307,
      "transaction_value": 1457630.6060000001,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "I",
      "nature_of_ownership": "By Trust",
      "footnotes": [
        {
          "id": "F1",
          "description": "The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."
        },
        {
          "id": "F2",
          "description": "The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.86 to $30.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.